<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132751">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01834378</url>
  </required_header>
  <id_info>
    <org_study_id>DIAVIP-1204</org_study_id>
    <secondary_id>Swedish Research Council</secondary_id>
    <nct_id>NCT01834378</nct_id>
  </id_info>
  <brief_title>Diabetes Prevention in Clinical Practice.</brief_title>
  <acronym>DIAVIP</acronym>
  <official_title>Diabetes Prevention in Primary Health Care With Special Emphasis on Physical Activity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <authority>Sweden: The National Board of Health and Welfare</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      We randomize individuals with impaired glucose tolerance to one of three arms for degree of
      physical activity: 1. Continue with your current life style; 2. Ordinary life activities for
      increased physical activity; 3. Scheduled group activities for changed behavior. The overall
      aim is to focus on change of physical activity and to keep other life style activities more
      or less unchanged (diet, smoking, etc) and the effect on metabolic variables.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>HOMA IR</measure>
    <time_frame>12 months after inclusion (baseline)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Insulin resistance according to HOMA</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low intensity intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High intensity intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low intensity intervention</intervention_name>
    <description>We administer, a pedometer and the participants receive a prescription on physical exercise.</description>
    <arm_group_label>Low intensity intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High intensity intervention.</intervention_name>
    <description>We schedule group sessions for changes in behavior e.g. type of physical activity to prefer, barriers for change of life style etc.</description>
    <arm_group_label>High intensity intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Impaired glucose tolerance

          2. Age: 20-85yrs

        Exclusion Criteria:

          1. Type2 diabetes

          2. Significant disease making life style changes unlikely to happen

          3. Unable to communicate in Swedish
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 5, 2014</lastchanged_date>
  <firstreceived_date>April 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>insulin resistance</keyword>
  <keyword>exercise</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
